PharmAbcine delivered a presentation at Access China Biotech Forum Winter Showcase 2022, January 4-14, 2022.

Dr. Hyunsun Park, Chief Brand Officer and Chief Operation Officer of PharmAbcine, joined a live meeting session where she introduced key antibody drug candidates, such as Olinvacimab, PMC-309, and PMC-403, to potential business partners.

Click the link for the video (Eng/Kor Sub available)